Hodgkin's lymphoma - The great teacher

New England Journal of Medicine

Volumn 365, Issue 3, 2011, Pages 264-265

  Connors, Joseph M ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADVANCED CANCER; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DRUG DOSE ESCALATION; DRUG TREATMENT FAILURE; EDITORIAL; EVENT FREE SURVIVAL; HODGKIN DISEASE; HUMAN; INFERTILITY; LAPAROTOMY; LEUKEMOGENESIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION HAZARD; SALVAGE THERAPY; SURVIVAL RATE; THERAPY RESISTANCE; TREATMENT OUTCOME;

EID: 79960577595     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1104576     Document Type: Editorial

References (8)

1. Viviani S, Zinzani PL, Rambaldi A, et al. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. N Engl J Med 2011;365:203-12.
2. Engert A, Plütschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010;363:640-52.
3. Meyer RM, Gospodarowicz MK, Connors JM, et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 2005;23:4634-42. (Pubitemid 46237440)
4. Engert A, Diehl V, Franklin J, et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009;27:4548-54.
5. Lavoie JC, Connors JM, Phillips GL, et al. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood 2005;106:1473-8. (Pubitemid 41129618)
6. Diehl V, Brillant C, Franklin J, et al. BEACOPP chemotherapy for advanced Hodgkin's disease: results of further analyses of the HD9- and HD12- trials of the German Hodgkin Study Group (GHSG). Blood 2004;104:91a-92a. abstract.
7. Moccia MA, Donaldson J, Chhanabhai M, et al. The International Prognostic Factor Project Score (IPS) in advanced stage Hodgkin lymphoma has limited utility in patients treated in the modern era. Blood 2009;114:622. abstract.
8. Aleman BM, Raemaekers JM, Tirelli U, et al. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 2003;348:2396-406. (Pubitemid 36682818)